Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by gudisgoodon Jan 17, 2022 3:47am
94 Views
Post# 34323420

RE:RE:Updated January Presentation

RE:RE:Updated January Presentation
Snowballgrowth wrote:
EbbFlow88 wrote: Shares outstanding as of Dec. 31st now showing 117.8M Shares outstanding. Since, I've bought Knight my % ownership has increased by almost 16%. Pretty wild.

This is very important. We all own 16 % more.


If the numbers in my Excel spreadsheet are correct, we had around 130M shares outstanding at the end of 2020, and now 117.8M at the end of 2021. That's more than a 9% decrease within a year.

Again, IF my Excel numbers are correct, in 2019 and 2020 the decreases were 5% and 4%, respectively.



<< Previous
Bullboard Posts
Next >>